Ricardo Marek is President of Emerging Markets Business Unit (EM BU), and a member of Takeda’s Executive Team, reporting to the Company’s CEO& President, Christophe Weber. Ricardo has over 25 years of experience in various industries and leadership roles. He has been with Takeda for 6 years and over this time he simultaneously held the roles of Area Head for Latin America (LATAM) since 2014, President for Brazil since 2013. Prior to that, he was Chief Financial Officer (CFO) of Brazil. Ricardo led the realignment and restructuring of the LATAM Area, positioning it as one of the top performers across EM BU, and Takeda Brazil as one of the top 10 pharmaceutical companies in the country. He also secured a number of acquisitions as well as launched the Oncology business in the region for Takeda’s potentially life-saving and life-transforming medicines. Under his leadership, Takeda was recognized for the first time as a Top Employer in all seven countries across the LATAM region, and also received several other HR awards, such as Great Place to Work®.   Before joining Takeda in 2011, Ricardo was CFO for Organon International in the US, and Managing Director and Vice President Finance for the Akzo Nobel Group in Brazil. He also has experience in other industries such as chemicals and aerospace.  A Brazilian national, Ricardo holds an MBA from the University of Sao Paulo, Brazil.

 Pharmaceutical industry